Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection: Epidemiology, pathogenesis and clinical characteristics

European Review for Medical and Pharmacological Sciences

Volumn 22, Issue 15, 2018, Pages 4956-4961

  Nassar, M S ^a   Bakhrebah, M A ^a   Meo, S A ^b   Alsuabeyl, M S ^a   Zaher, W A ^c,d  

^a KING ABDULAZIZ CITY FOR SCIENCE AND TECHNOLOGY   (Saudi Arabia)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

^c KING SAUD UNIVERSITY   (Saudi Arabia)

^d Abu Dhabi Health Services Co   (United Arab Emirates)

Author keywords

(MERS CoV); Coronavirus; Epidemiology; Middle East Respiratory Syndrome; Pathogenesis

Indexed keywords

AFRICA; ARTICLE; ASIA; CHILL; CHRONIC DISEASE; CLINICAL FEATURE; COUGHING; DIABETES MELLITUS; DIARRHEA; DYSPNEA; EARLY DIAGNOSIS; EARLY INTERVENTION; END STAGE RENAL DISEASE; EUROPE; FEVER; GLOBAL DISEASE BURDEN; GLOBAL HEALTH; HUMAN; LUNG DISEASE; MALIGNANT NEOPLASM; MEDICAL DOCUMENTATION; MIDDLE EAST; MIDDLE EAST RESPIRATORY SYNDROME; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; MORTALITY RATE; MYALGIA; NAUSEA; NONHUMAN; NORTH AMERICA; PATHOGENESIS; PREVALENCE; SAUDI ARABIA; SYSTEMATIC REVIEW; VIRUS TRANSMISSION; VOMITING; WORLD HEALTH ORGANIZATION; ADULT; AGED; COMPLICATION; CORONAVIRUS INFECTION; FACTUAL DATABASE; FEMALE; ISOLATION AND PURIFICATION; MALE; MIDDLE AGED; MORTALITY; PATHOLOGY; SURVIVAL RATE;

ADULT; AGED; CORONAVIRUS INFECTIONS; DATABASES, FACTUAL; DIARRHEA; FEMALE; FEVER; GLOBAL HEALTH; HUMANS; MALE; MIDDLE AGED; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; PREVALENCE; SAUDI ARABIA; SURVIVAL RATE; VOMITING;

EID: 85066470054     PISSN: 11283602     EISSN: 22840729     Source Type: Journal    
DOI: 10.26355/EURREV_201808_15635     Document Type: Article

References (34)

1. ZAKI AM, VAN BS, BESTEBROER TM, OSTERHAUS AD, FOUCHIER RA. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med 2012; 367: 1814-1820.
2. MAJUMDER MS, RIVERS C, LOFGREN E, FISMAN D. Estimation of MERS-Coronavirus reproductive number and case fatality rate for the spring 2014 Saudi Arabia outbreak: insights from publicity available data. PLoS Currents Outbreaks 2014; 1: 1-18.
3. WHO: MERS SITUATION UPDATE: AVAILABLE AT: HTTP://WWW.emro.who.int/pandemic-epidemic-diseases/mers-cov/mers-situation-update-april-2018.html, cited date May 2, 2018.
4. ALQAHTANI AS, RASHID H, BASYOUNI MH, ALHAWASSI TM, BINDHIM NF. Public response to MERS-CoV in the Middle East: iPhone survey in six countries. J Infect Pub Health 2017; 10: 534-540.
5. ALY M, ELROBH M, ALZAYER M, ALJUHANI S, BALKHY H. Occurrence of the Middle East Respiratory Syndrome Coronavirus (MERS-CoV) across the Gulf Corporation Council countries: Four years update. PLoS One 2017; 12: e0183850.
6. ITHETE NL, STOFFBERG S, CORMAN VM, COTTONTAIL VM, RICHARDS LR, SCHOEMAN MC, DROSTEN C, DREXLER JF, PREISER W. Close relative of human middle East respiratory syndrome coronavirus in bat South Africa. Emerg Infect Dis 2013; 19: 1697-1699.
7. GE XY, LI JL, YANG XL, CHMURA AA, ZHU G, EPSTEIN JH. Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor. Nature 2013; 503: 535-533.
8. RAJ VS, OSTERHAUS ADME, FOUCHIER RAM, HAAGMANS BL. MERS: emergence of a novel human coronavirus. Curr Opin Virol 2014; 5: 58-62.
9. RAJ VS, SMITS SL, PROVACIA LB, VANDEN BRAND JM, WIERSMA L, OUWENDIJK WJ. Adenosine deaminase acts as a natural antagonist for dipeptidyl peptidase 4 mediated entry of the Middle East respiratory syndrome coronavirus. J Virol 2014; 88: 1834-1838.
10. WOO PC, LAU SK, LI KS, TSANG AK, YUEN KY. Genetic relatedness of the novel human group C betacoronavirus to Tylonycteris bat coronavirus HKU4 and Pipistrellus bat coronavirus HKU5. Emerg Microbes Infect 2012; 1: e35.
11. KAYALI G, PEIRIS M. A more detailed picture of the epidemiology of Middle East respiratory syndrome coronavirus. Lancet Infect Dis 2015; 15: 495-497.
12. CHAN RW, HEMIDA MG, KAYALI G, CHU DK, POON LL, ALNAEEM. Tropism and replication of Middle East respiratory syndrome coronavirus from dromedary camels in the human respiratory tract: an in-vitro and ex-vivo study. Lancet Respir Med 2014; 2: 813-822.
13. YUSOF MF, ELTAHIR YM, SERHAN WS, HASHEM FM, ELSAYED EA, MARZOUG BA. Prevalence of Middle East respiratory syndrome coronavirus (MERS-CoV) in dromedary camels in Abu Dhabi Emirate, United Arab Emirates. Virus Genes 2015; 50: 509-513.
14. MILNE-PRICE S, MIAZGOWICZ KL, MUNSTER VJ. The emergence of the Middle East respiratory syndrome coronavirus (MERS-CoV). Pathog Dis 2014; 71: 121-136.
15. MULLER MA, CORMAN VM, JORES J, MEYER B, YOUNAN M, LILJANDER A. MERS coronavirus neutralizing antibodies in camels Eastern Africa, 1983-1997. Emerg Infect Dis 2014; 20: 2093-2095.
16. CORMAN VM, KALLIES R, PHILIPPS H, GOPNER G, MULLER MA, ECKERLE I, BRUNINK S, DROSTEN C, DREXLER JF. Characterization of a novel betacoronavirus related to Middle East respiratory syndrome coronavirus in European hedgehogs. J Virol 2014; 88: 717-724.
17. CORMAN VM, JORES J, MEYER B, YOUNAN M, LILJANDER A, SAID MY. Antibodies against MERS coronavirus in dromedary camels, Kenya, 1992-2013. Emerg Infect Dis 2014; 20: 1319-1322.
18. ZUMLA A, HUI DS, PERLMAN S. Middle East respiratory syndrome. Lancet 2015; 386: 995-1007.
19. LEE JY, KIM YJ, CHUNG EH, KIM DW, JEONG I, KIM Y, YUN MR, KIM SS, KIM G, JOH JS. The clinical and virological features of the first imported case causing MERS-CoV outbreak in South Korea, 2015. BMC Infect Dis 2017; 17: 498.
20. ALSAAD KO, HAJEER AH, AL BALWI M, AL MOAIQEL M, AL OUDAH N, AL AJLAN A. Histopathology of Middle East respiratory syndrome coronovirus (MERS-CoV) infection – clinic-pathological and ultrastructural study. Histopathology 2018; 72: 516-524.
21. ASSIRI A, MCGEER A, PERL TM, PRICE CS, AL RABEEAH AA, CUMMINGS DA. Hospital outbreak of middle east respiratory syndrome coronavirus. N Engl J Med 2013; 369: 407-416.
22. COTTEN M, WATSON SJ, KELLAM P, AL–RABEEAH AA, MAKHDOOM HQ, ASSIRI A, AL-TAWFIQ JA, ALHAKEEM RF, MADANI H, ALRABIAH FA. Transmission and evolution of the Middle East respiratory syndrome coronavirus in Saudi Arabia: a descriptive genomic study. Lancet 2013; 382: 1993-2002.
23. MEMISH ZA, ZUMLA AI, AL-HAKEEM RF, AL-RABEEAH AA, STEPHENS GM. Family cluster of Middle East respiratory syndrome coronavirus infections. N Engl J Med 2013; 368: 2487-2494.
24. HUNTER JC, NGUYEN D, ADEN B, AL BANDAR Z, AL DHAHERI W, ELKHEIR KA. Transmission of Middle East respiratory syndrome coronavirus infections in healthcare settings, Abu Dhabi. Emerg Infect Dis 2016; 22: 647-656.
25. SHARIF-YAKAN A, KANJ SS. Emergence of MERS-CoV in the Middle East: origins, transmission, treatment and perspectives. PLoS Pathog 2014; 10: e1004457.
26. HAWKES N. MERS coronovirus has probably been present in bats for many years, research shows. BMJ 2013; 347: f 6141.
27. KUPFERSCHMIDT K. Emerging infectious diseases. Link to MERS virus underscores bats’ puzzling threat. Science 2013; 341: 948-949.
28. MEMISH ZA, MISHRA N, OLIVAL KJ, FAGBO SF, KAPOOR V, EPSTEIN JH. Middle East respiratory syndrome coronavirus in bats, Saudi Arabia. Emerg Infect Dis 2013; 19: 1819-1823.
29. VAN DOREMALEN N, MUNSTER VJ. Animal models of Middle East respiratory syndrome coronavirus infection. Antiviral Res 2015; 122: 28-38.
30. MEMISH ZA. MERS-CoV an emerging viral zoonotic disease: three years after and counting. Recent Pat Antiinfect Drug Discov 2014; 9: 1590160.
31. NASSAR MS, BAKHREBAH MA, ALSUABEYL MS, ZAHER WA, MEO SA. Global seasonal occurrence of middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection. Eur Rev Med Pharmacol Sci 2018; 22: 3912-3917.
32. WHO MERS-COV RESEARCH GROUP. State of knowledge and data gaps of Middle East respiratory syndrome coronavirus (MERS-CoV) in humans. PLoS Curr 2013; 5: pii: 0bf 719e352.
33. MOORE BB, MOORE TA. Viruses in idiopathic pulmonary fibrosis. Etiology and exacerbation. Ann Am Thorac Soc 2015; 12: S186-192.
34. MOLYNEAUX PL, COX MJ, WILLIS-OWEN SA, MALLIA A, RUSSELL KE, RUSSELL AM. The role of bacteria in the pathogenesis and progression of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2014; 190: 906-1913.